STERIS (NYSE: STE) Reports Fiscal Q4 Beat; Stock Falls Despite Earnings Surprise
STERIS beat EPS estimates in fiscal Q4 but shares declined 2.70% as investors weighed the results on Monday.
STERIS plc (NYSE: STE) is a company in the Health Care sector, listed on the NYSE. This page collects all Alpha Stocks Insight coverage of STE: earnings reports, analyst actions, and company news, updated as new articles are published. 2 articles since May 11, 2026.
STERIS stock surged on Tuesday, May 12, even after reporting Q4 results that fell short of consensus expectations.
STERIS beat EPS estimates in fiscal Q4 but shares declined 2.70% as investors weighed the results on Monday.
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.
Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.